BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY— 510(k) K010668

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K010668 for BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY, Substantially Equivalent on 2001-07-05. Applicant: Bayer Corp..

Clearance details

Applicant: Bayer Corp.
Product code: Code LFX
Advisory panel: Microbiology
Date received: 2001-03-06
Decision date: 2001-07-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.